SING GEORGE L
SEC Form 4 insider trading activity
SING GEORGE L has filed 3 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Nov 4, 2026.
On the most recent filing, SING GEORGE L is listed as Director at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, SING GEORGE L reported no open-market purchases and 1 open-market sale totaling $20.4M in REGN.
Companies traded
Other insiders at REGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$20.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SING GEORGE L made?
SING GEORGE L has filed 3 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does SING GEORGE L trade?
SING GEORGE L has filed SEC Form 4 disclosures for 1 company, including REGN.
When was SING GEORGE L's most recent SEC Form 4 filing?
SING GEORGE L's most recent SEC Form 4 filing on Tracefour is dated Nov 4, 2026.
What is SING GEORGE L's total buy and sell value in the current window?
Inside the rolling retention window, SING GEORGE L bought $0 and sold $20.4M based on SEC Form 4 filings.
What was SING GEORGE L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 21,129 REGN shares on 2026-11-02, worth $20.4M, per SEC Form 4 filings.